The medical exoskeleton market size has grown exponentially in recent years. It will grow from $0.53 billion in 2025 to $0.66 billion in 2026 at a compound annual growth rate (CAGR) of 25.2%. The growth in the historic period can be attributed to limited availability of powered exoskeletons, high cost of early robotic devices, low awareness of rehabilitation robotics, reliance on passive exoskeletons, fragmented healthcare infrastructure.
The medical exoskeleton market size is expected to see exponential growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 24.9%. The growth in the forecast period can be attributed to technological advancements in AI-assisted exoskeletons, expansion of rehabilitation centers globally, increasing investment in mobility-impaired patient care, rising integration with wearable monitoring and IoT devices, development of lightweight and ergonomic exoskeleton designs. Major trends in the forecast period include rising adoption of exoskeletons in rehabilitation centers, increasing use of lower and upper limb support devices, expansion of full-body exoskeleton applications, growing integration with wearable sensors and monitoring systems, focus on ergonomics and user comfort for daily use.
The increase in spinal cord and brain injuries is increasingly supporting the expansion of the medical exoskeleton market going forward. Spinal cord and brain injuries involve traumatic damage to the central nervous system, often resulting in substantial impairment of motor, sensory, and cognitive functions. The rise in spinal cord and brain injuries is largely associated with higher incidences of vehicular accidents, falls, sports-related injuries, and violent incidents. Medical exoskeletons assist individuals with spinal cord and brain injuries by supporting mobility and rehabilitation, enhancing physical strength, and enabling improved functional movement. For example, in October 2023, according to the World Federation of Neurology, a UK-based organization dedicated to advancing neurological research and practice, more than 40% of the global population was affected by a neurological condition, with projections indicating this burden could nearly double by 2050. As a result, the increasing incidence of spinal cord and brain injuries is contributing to the expansion of the medical exoskeleton market.
Leading companies operating in the medical exoskeleton market are focusing on integrating smart powering mechanism technologies to improve workforce efficiency and support the nursing profession amid ongoing labor shortages. A smart robotic exoskeleton is a wearable robotic system designed to enhance the physical capabilities of the human body. For example, in December 2023, German Bionic, a Germany-based automation machinery manufacturing company, launched the Apogee+ e-exoskeleton. This device is designed to assist healthcare professionals by providing dynamic lifting support and facilitating patient mobilization. It reduces up to 66 pounds (30 kg) of back strain, supporting activities such as patient transfers, medical examinations, and repositioning. The Apogee+ incorporates a safety-focused closed structure and specialized grips to mitigate physical risks, enhancing safety for both caregivers and patients. Its ergonomic design supports effective nurse-patient interaction by combining robotic assistance with human-centered engineering.
In August 2023, ReWalk Robotics Ltd., a US-based technology company, acquired AlterG, Inc. for an undisclosed amount. Through this acquisition, ReWalk sought to enhance its clinical and home rehabilitation offerings by integrating AlterG’s anti-gravity systems, enabling precisely controlled, gravity-reduced movement therapy, and supporting its path toward profitability. AlterG is a US-based company that provides medical exoskeleton and rehabilitation solutions.
Major companies operating in the medical exoskeleton market are Honda, Panasonic Holdings Corporation, Parker Hannifin Corporation, Ottobock SE & Co KGaA, DIH International Limited, Fourier Intelligence, Cyberdyne Inc, GBS German Bionic Systems GmbH, Hocoma AG, Neofect, Bionic Yantra, Ekso Bionics Holdings Inc., Hexar Humancare, MediTouch, Suit X, ReWalk Robotics, Rex Bionics Ltd, Human Motion Technologies LLC, Guangzhou Yikang Medical Equipment, NextStep Robotics, Marsi Bionics, Focal Meditech, Gogoa Mobility Robots, B-Temia, Rehab-Robotics Company Limited, Roam Robotics, Bionik Laboratories Inc.
North America was the largest region in the medical exoskeleton market in 2025. The regions covered in the medical exoskeleton market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical exoskeleton market by increasing the cost of imported robotic components, sensors, and control systems. Powered exoskeleton segments, particularly full-body and lower limb devices, are most impacted, with Asia-Pacific regions such as China and Japan facing higher import duties. These tariffs have led to increased product prices and slowed adoption in certain regions. On the positive side, tariffs have encouraged local manufacturing, boosted innovation in component sourcing, and supported the development of domestic exoskeleton production capabilities.
The medical exoskeleton market research report is one of a series of new reports that provides medical exoskeleton market statistics, including medical exoskeleton industry global market size, regional shares, competitors with a medical exoskeleton market share, detailed medical exoskeleton market segments, market trends and opportunities, and any further data you may need to thrive in the medical exoskeleton industry. This medical exoskeleton market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A medical exoskeleton is a wearable robotic system that supports and enhances body movement, helping people with mobility impairments during rehabilitation and daily activities by improving strength, stability, and functional mobility.
The primary types of medical exoskeletons include powered exoskeletons and passive exoskeletons. Powered exoskeletons are wearable systems that utilize motors or actuators to assist or enhance user movement, offering powered support to improve mobility, support rehabilitation, or augment physical performance for different tasks. The components include hardware and software, and the mobility types are categorized as stationary and mobile. The supported extremities include lower body, upper body, and full body, with applications such as spinal cord injury, stroke, and others.
The medical exoskeleton market consists of sales of robotic exoskeletons, wearable exoskeletons, and orthotic exoskeletons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medical exoskeleton market size is expected to see exponential growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 24.9%. The growth in the forecast period can be attributed to technological advancements in AI-assisted exoskeletons, expansion of rehabilitation centers globally, increasing investment in mobility-impaired patient care, rising integration with wearable monitoring and IoT devices, development of lightweight and ergonomic exoskeleton designs. Major trends in the forecast period include rising adoption of exoskeletons in rehabilitation centers, increasing use of lower and upper limb support devices, expansion of full-body exoskeleton applications, growing integration with wearable sensors and monitoring systems, focus on ergonomics and user comfort for daily use.
The increase in spinal cord and brain injuries is increasingly supporting the expansion of the medical exoskeleton market going forward. Spinal cord and brain injuries involve traumatic damage to the central nervous system, often resulting in substantial impairment of motor, sensory, and cognitive functions. The rise in spinal cord and brain injuries is largely associated with higher incidences of vehicular accidents, falls, sports-related injuries, and violent incidents. Medical exoskeletons assist individuals with spinal cord and brain injuries by supporting mobility and rehabilitation, enhancing physical strength, and enabling improved functional movement. For example, in October 2023, according to the World Federation of Neurology, a UK-based organization dedicated to advancing neurological research and practice, more than 40% of the global population was affected by a neurological condition, with projections indicating this burden could nearly double by 2050. As a result, the increasing incidence of spinal cord and brain injuries is contributing to the expansion of the medical exoskeleton market.
Leading companies operating in the medical exoskeleton market are focusing on integrating smart powering mechanism technologies to improve workforce efficiency and support the nursing profession amid ongoing labor shortages. A smart robotic exoskeleton is a wearable robotic system designed to enhance the physical capabilities of the human body. For example, in December 2023, German Bionic, a Germany-based automation machinery manufacturing company, launched the Apogee+ e-exoskeleton. This device is designed to assist healthcare professionals by providing dynamic lifting support and facilitating patient mobilization. It reduces up to 66 pounds (30 kg) of back strain, supporting activities such as patient transfers, medical examinations, and repositioning. The Apogee+ incorporates a safety-focused closed structure and specialized grips to mitigate physical risks, enhancing safety for both caregivers and patients. Its ergonomic design supports effective nurse-patient interaction by combining robotic assistance with human-centered engineering.
In August 2023, ReWalk Robotics Ltd., a US-based technology company, acquired AlterG, Inc. for an undisclosed amount. Through this acquisition, ReWalk sought to enhance its clinical and home rehabilitation offerings by integrating AlterG’s anti-gravity systems, enabling precisely controlled, gravity-reduced movement therapy, and supporting its path toward profitability. AlterG is a US-based company that provides medical exoskeleton and rehabilitation solutions.
Major companies operating in the medical exoskeleton market are Honda, Panasonic Holdings Corporation, Parker Hannifin Corporation, Ottobock SE & Co KGaA, DIH International Limited, Fourier Intelligence, Cyberdyne Inc, GBS German Bionic Systems GmbH, Hocoma AG, Neofect, Bionic Yantra, Ekso Bionics Holdings Inc., Hexar Humancare, MediTouch, Suit X, ReWalk Robotics, Rex Bionics Ltd, Human Motion Technologies LLC, Guangzhou Yikang Medical Equipment, NextStep Robotics, Marsi Bionics, Focal Meditech, Gogoa Mobility Robots, B-Temia, Rehab-Robotics Company Limited, Roam Robotics, Bionik Laboratories Inc.
North America was the largest region in the medical exoskeleton market in 2025. The regions covered in the medical exoskeleton market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical exoskeleton market by increasing the cost of imported robotic components, sensors, and control systems. Powered exoskeleton segments, particularly full-body and lower limb devices, are most impacted, with Asia-Pacific regions such as China and Japan facing higher import duties. These tariffs have led to increased product prices and slowed adoption in certain regions. On the positive side, tariffs have encouraged local manufacturing, boosted innovation in component sourcing, and supported the development of domestic exoskeleton production capabilities.
The medical exoskeleton market research report is one of a series of new reports that provides medical exoskeleton market statistics, including medical exoskeleton industry global market size, regional shares, competitors with a medical exoskeleton market share, detailed medical exoskeleton market segments, market trends and opportunities, and any further data you may need to thrive in the medical exoskeleton industry. This medical exoskeleton market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A medical exoskeleton is a wearable robotic system that supports and enhances body movement, helping people with mobility impairments during rehabilitation and daily activities by improving strength, stability, and functional mobility.
The primary types of medical exoskeletons include powered exoskeletons and passive exoskeletons. Powered exoskeletons are wearable systems that utilize motors or actuators to assist or enhance user movement, offering powered support to improve mobility, support rehabilitation, or augment physical performance for different tasks. The components include hardware and software, and the mobility types are categorized as stationary and mobile. The supported extremities include lower body, upper body, and full body, with applications such as spinal cord injury, stroke, and others.
The medical exoskeleton market consists of sales of robotic exoskeletons, wearable exoskeletons, and orthotic exoskeletons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medical Exoskeleton Market Characteristics
3. Medical Exoskeleton Market Supply Chain Analysis
4. Global Medical Exoskeleton Market Trends and Strategies
5. Medical Exoskeleton Market Analysis of End Use Industries
7. Global Medical Exoskeleton Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medical Exoskeleton Total Addressable Market (TAM) Analysis for the Market
9. Medical Exoskeleton Market Segmentation
10. Medical Exoskeleton Market Regional and Country Analysis
11. Asia-Pacific Medical Exoskeleton Market
12. China Medical Exoskeleton Market
13. India Medical Exoskeleton Market
14. Japan Medical Exoskeleton Market
15. Australia Medical Exoskeleton Market
16. Indonesia Medical Exoskeleton Market
17. South Korea Medical Exoskeleton Market
18. Taiwan Medical Exoskeleton Market
19. South East Asia Medical Exoskeleton Market
20. Western Europe Medical Exoskeleton Market
21. UK Medical Exoskeleton Market
22. Germany Medical Exoskeleton Market
23. France Medical Exoskeleton Market
24. Italy Medical Exoskeleton Market
25. Spain Medical Exoskeleton Market
26. Eastern Europe Medical Exoskeleton Market
27. Russia Medical Exoskeleton Market
28. North America Medical Exoskeleton Market
29. USA Medical Exoskeleton Market
30. Canada Medical Exoskeleton Market
31. South America Medical Exoskeleton Market
32. Brazil Medical Exoskeleton Market
33. Middle East Medical Exoskeleton Market
34. Africa Medical Exoskeleton Market
36. Medical Exoskeleton Market Competitive Landscape and Company Profiles
37. Medical Exoskeleton Market Other Major and Innovative Companies
40. Medical Exoskeleton Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medical Exoskeleton Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical exoskeleton market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical exoskeleton? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical exoskeleton market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Powered Exoskeletons; Passive Exoskeletons2) By Component: Hardware; Software
3) By Mobility: Stationary; Mobile
4) By Extremities: Lower; Upper; Full Body
5) By Application: Spinal Cord Injury; Stroke; Other Applications
Subsegments:
1) By Powered Exoskeletons: Lower Limb Exoskeletons; Upper Limb Exoskeletons; Full-Body Exoskeletons; Rehabilitation Exoskeletons; Industrial Exoskeletons2) By Passive Exoskeletons: Lower Limb Passive Exoskeletons; Upper Limb Passive Exoskeletons; Posture-Support Exoskeletons; Assistive Devices for Daily Living
Companies Mentioned: Honda; Panasonic Holdings Corporation; Parker Hannifin Corporation; Ottobock SE & Co KGaA; DIH International Limited; Fourier Intelligence; Cyberdyne Inc; GBS German Bionic Systems GmbH; Hocoma AG; Neofect; Bionic Yantra; Ekso Bionics Holdings Inc.; Hexar Humancare; MediTouch; Suit X; ReWalk Robotics; Rex Bionics Ltd; Human Motion Technologies LLC; Guangzhou Yikang Medical Equipment; NextStep Robotics; Marsi Bionics; Focal Meditech; Gogoa Mobility Robots; B-Temia; Rehab-Robotics Company Limited; Roam Robotics; Bionik Laboratories Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Exoskeleton market report include:- Honda
- Panasonic Holdings Corporation
- Parker Hannifin Corporation
- Ottobock SE & Co KGaA
- DIH International Limited
- Fourier Intelligence
- Cyberdyne Inc
- GBS German Bionic Systems GmbH
- Hocoma AG
- Neofect
- Bionic Yantra
- Ekso Bionics Holdings Inc.
- Hexar Humancare
- MediTouch
- Suit X
- ReWalk Robotics
- Rex Bionics Ltd
- Human Motion Technologies LLC
- Guangzhou Yikang Medical Equipment
- NextStep Robotics
- Marsi Bionics
- Focal Meditech
- Gogoa Mobility Robots
- B-Temia
- Rehab-Robotics Company Limited
- Roam Robotics
- Bionik Laboratories Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.66 Billion |
| Forecasted Market Value ( USD | $ 1.62 Billion |
| Compound Annual Growth Rate | 24.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
